Cite
Williams TE, Subramanian S, Verhagen J, et al. Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma. ACS Med Chem Lett. 2015;6(9):961-5doi: 10.1021/ml500526p.
Williams, T. E., Subramanian, S., Verhagen, J., McBride, C. M., Costales, A., Sung, L., Antonios-McCrea, W., McKenna, M., Louie, A. K., Ramurthy, S., Levine, B., Shafer, C. M., Machajewski, T., Renhowe, P. A., Appleton, B. A., Amiri, P., Chou, J., Stuart, D., Aardalen, K., & Poon, D. (2015). Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma. ACS medicinal chemistry letters, 6(9), 961-5. https://doi.org/10.1021/ml500526p
Williams, Teresa E, et al. "Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma." ACS medicinal chemistry letters vol. 6,9 (2015): 961-5. doi: https://doi.org/10.1021/ml500526p
Williams TE, Subramanian S, Verhagen J, McBride CM, Costales A, Sung L, Antonios-McCrea W, McKenna M, Louie AK, Ramurthy S, Levine B, Shafer CM, Machajewski T, Renhowe PA, Appleton BA, Amiri P, Chou J, Stuart D, Aardalen K, Poon D. Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma. ACS Med Chem Lett. 2015 Aug 03;6(9):961-5. doi: 10.1021/ml500526p. eCollection 2015 Sep 10. PMID: 26396681; PMCID: PMC4569875.
Copy
Download .nbib